Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data

Abstract In this commentary, we review clinical data which helps inform individualized benefit–risk assessment for tofacitinib in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS). ORAL Surveillance, a safety trial of patients ≥ 50 years of age with rheumatoid arthritis (RA) an...

Full description

Bibliographic Details
Main Authors: Lars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D. Kinch, Dafna D. Gladman
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-05-01
Series:Rheumatology and Therapy
Subjects:
Age
Ankylosing spondylitis
Cardiovascular disease
Psoriatic arthritis
Tofacitinib
Smoking
Online Access:https://doi.org/10.1007/s40744-024-00662-5

Internet

https://doi.org/10.1007/s40744-024-00662-5

Similar Items